Page last updated: 2024-10-27

fenofibrate and Carcinoma, Squamous Cell of Head and Neck

fenofibrate has been researched along with Carcinoma, Squamous Cell of Head and Neck in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, J1
Ge, YY1
Zhu, HC1
Yang, X1
Cai, J1
Zhang, C1
Lu, J1
Zhan, LL1
Qin, Q1
Yang, Y1
Yang, YH1
Zhang, H1
Chen, XC1
Liu, ZM1
Ma, JX1
Cheng, HY1
Sun, XC1

Other Studies

1 other study available for fenofibrate and Carcinoma, Squamous Cell of Head and Neck

ArticleYear
Fenofibrate increases radiosensitivity in head and neck squamous cell carcinoma via inducing G2/M arrest and apoptosis.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:16

    Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; CDC2 Protein Kinase; Cell Line, Tumor; Cell

2014